{"id":30829,"date":"2024-04-17T07:50:00","date_gmt":"2024-04-17T07:50:00","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=30829"},"modified":"2024-04-17T02:56:38","modified_gmt":"2024-04-17T02:56:38","slug":"beckman-coulter-launches-new-hepatitis-assays-on-its-dxi-9000-immunoassay-analyzer","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/beckman-coulter-launches-new-hepatitis-assays-on-its-dxi-9000-immunoassay-analyzer\/","title":{"rendered":"Beckman Coulter Launches New Hepatitis Assays on its DxI 9000 Immunoassay Analyzer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Beckman Coulter Diagnostics has expanded the menu of assays available on its <a href=\"https:\/\/www.beckmancoulter.com\/en\/products\/immunoassay\/dxi-9000-access-immunoassay-analyzer\" target=\"_blank\" rel=\"noreferrer noopener\">DxI 9000 Immunoassay Analyzer<\/a> following CE mark approval of tests for hepatitis B and C viruses, namely Access anti-HCV, Access HBsAg and Access HBsAg Confirory assays.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Beckman Coulter&#8217;s validated HBsAg High Positive algorithm eliminates the need for repeat and confirmatory testing for samples \u2265 100.00 S\/CO and can directly report 96.9% of initially reactive specimens as positive, providing laboratories with accurate results. The assay is intended to be used as an aid in the diagnosis of HBV infection and as a screening test for blood and plasma donors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To view the source version, please click <a href=\"https:\/\/www.beckmancoulter.com\/en\/about-beckman-coulter\/newsroom\/press-releases\/2024\/q2\/dxi-9000-immunoassay-analyzer-extends-menu-new-ce-marked-hepatitis-assays-at-escmid-global\" target=\"_blank\" rel=\"noopener\">HERE<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beckman Coulter Diagnostics has expanded the menu of assays available on its DxI 9000 Immunoassay Analyzer following CE mark approval of tests for hepatitis B and C viruses,<\/p>\n","protected":false},"author":2,"featured_media":30830,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[6,675,25],"tags":[704],"class_list":["post-30829","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe","category-ivds","category-products-technologies","tag-ce-mark"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/30829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=30829"}],"version-history":[{"count":6,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/30829\/revisions"}],"predecessor-version":[{"id":30837,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/30829\/revisions\/30837"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/30830"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=30829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=30829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=30829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}